Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prognostic factors in osteosarcomas. A regression analysis.

S M Bentzen1, H S Poulsen, S Kaae

  • 1Department of Oncology, Radiumstationen, Aarhus, Denmark.

Cancer
|July 1, 1988
PubMed
Summary

This study identifies key prognostic factors for osteosarcoma survival, revealing that tumor location and symptom duration impact outcomes. Young adults aged 25-30 with specific tumor cell types had the best prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Report of the sixth Nordic Family Health and Care Conference 2024: Sharing Interdisciplinary Work to Improve the Health and Well-Being of Families.

Journal of family nursing·2024
Same author

Atrial fibrillation in cryptogenic stroke and TIA patients in The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Main results.

European stroke journal·2023
Same author

Toxicity and efficacy of lomustine and bevacizumab in recurrent glioblastoma patients.

Journal of neuro-oncology·2018
Same author

Prognostic value of O-6-methylguanine-DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis.

Neuropathology and applied neurobiology·2017
Same author

A comprehensive profile of recurrent glioblastoma.

Oncogene·2016
Same author

Status Report--Retracing the history of the early development of national chronic disease surveillance in Canada and the major role of the Laboratory Centre for Disease Control (LCDC) from 1972 to 2000.

Health promotion and chronic disease prevention in Canada : research, policy and practice·2015

Area of Science:

  • Oncology
  • Medical Statistics
  • Cancer Research

Background:

  • Osteosarcoma is a primary bone malignancy with variable prognosis.
  • Accurate prognostic indicators are crucial for tailoring treatment and improving patient outcomes.
  • Previous studies have explored various factors influencing osteosarcoma survival.

Purpose of the Study:

  • To identify clinical and pathological variables that predict survival in osteosarcoma patients.
  • To develop a prognostic index for stratifying patients based on their likelihood of survival.
  • To analyze long-term survival trends and mortality risks in osteosarcoma survivors.

Main Methods:

  • Retrospective analysis of 184 previously untreated osteosarcoma patients.
  • Application of the Cox proportional hazards model (PHM) for survival data analysis.

Related Experiment Videos

  • Evaluation of clinical and pathological variables for prognostic significance.

    • Main Results:

    • Poor prognostic indicators included tumors of the trunk, pelvis, or femur, and symptom duration < 6 months.
    • Favorable prognostic signs were tumors with a high proportion of fibroblastic cells and patient age around 25-30 years.
    • Prognosis worsened with increasing age; children and adolescents (5-25 years) had poorer outcomes than young adults (25-30 years).
    • Overall 10-year survival was 28.6 +/- 3.5%; mortality risk remained elevated even 10 years post-treatment.

    Conclusions:

    • Tumor location, symptom duration, patient age, and specific tumor histology are significant prognostic factors in osteosarcoma.
    • A prognostic index derived from these factors can aid in patient stratification.
    • Long-term survival remains a concern, with continued mortality risk in osteosarcoma survivors.